Yong, Wee V

Fundamental Research

Professor

Web Presence:

Yong Lab

Biography

Dr. V. Wee Yong is a Professor at the University of Calgary. He holds the Canada Research Chair (Tier 1) in Neuroimmunology. Dr. Yong co-directs the Multiple Sclerosis (MS) NeuroTeam of the Hotchkiss Brain Institute in Calgary, providing the basic science leadership, and he directs the provincial Alberta MS Network.  Dr. Yong is a past chair of the Medical Advisory Committee of the MS Society of Canada; this and other volunteer activities resulted in him receiving the Queen’s Golden Jubilee Year Medallion.  Dr. Yong is on the editorial board of 7 international journals, and he is the Honorary Editor-in-Chief of the Neuroimmunology and Neuroinflammation journal. He has been the President of the International Society of Neuroimmunology (2014-2016). Dr. Yong is an elected fellow of both the Canadian Academy of Health Sciences (2010) and the Royal Society of Canada (2014), which represent top honors for those working in the medical and academic sciences, respectively. He was awarded the 2017 Allyn Taylor International Prize in Medicine for his transformational discoveries in MS

Area of Focus

  • Neuroimmunology
  • Neuroprotection
  • CNS regeneration
  • MS and brain tumors

Summary of Research

Dr. Yong’s research interests lie in the area of neuroimmunology, neuroprotection and CNS regeneration, and his projects are guided by MS and brain tumors.  Dr. Yong has published 340 peer-reviewed manuscripts and his research has been translated into clinical trials in MS, spinal cord injury and glioblastoma.  His work has been cited over 24,000 times (Web of Science, h index: 87) by other authors in scientific publications.

Area Of Focus

  • Neuroimmunology
  • Neuroprotection
  • CNS regeneration
  • MS and brain tumors

Summary Of Research

Dr. Yong’s research interests lie in the area of neuroimmunology, neuroprotection and CNS regeneration, and his projects are guided by MS and brain tumors.  Dr. Yong has published 340 peer-reviewed manuscripts and his research has been translated into clinical trials in MS, spinal cord injury and glioblastoma.  His work has been cited over 24,000 times (Web of Science, h index: 87) by other authors in scientific publications.